Saint Genis Laval, France

Pierre-François Serres

This inventor holds 2 USPTO granted patents. Top assignees: Lomastar Technologies Sarl, Mymetics Corporation. Active years: 2010-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre-François Serres. Retrieved from https://idiyas.com/inventor/pierre-francois-serres

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.7

ph-index = 1


Company Filing History:


Years Active: 2010-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pierre-François Serres: Innovator in HIV Research

Introduction

Pierre-François Serres is a notable inventor based in Saint Genis Laval, France. He has made significant contributions to the field of HIV research through his innovative work on polypeptides.

Latest Patents

Serres holds a patent for a "Soluble and stabilized trimeric form of gp41 polypeptides." This invention involves a modified polypeptide that contains an immunodominant region and the connecting loop between the N- and C-helices of the gp41 ectodomain of HIV-1. The connecting loop includes a linker fragment that maintains the native conformation of the interaction between the N- and C-helices while ensuring sufficient hydrophilicity to provide a soluble and stable trimeric form of the modified polypeptide.

Career Highlights

Pierre-François Serres is associated with Mymetics Corporation, where he continues to advance research in the field of immunology and HIV. His work has been instrumental in developing new therapeutic approaches to combat HIV.

Collaborations

He has collaborated with notable colleagues such as Sylvain Fleury and Marc P Girard, contributing to the advancement of research in their field.

Conclusion

Pierre-François Serres is a distinguished inventor whose work on gp41 polypeptides has the potential to impact HIV treatment significantly. His innovative contributions continue to shape the landscape of immunological research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…